Advertisement

Topics

Mylan finalizes $465M settlement for EpiPen

10:55 EDT 17 Aug 2017 | BioPharmaDive

The payment, though, is just a fraction of the $1.3 billion the U.S. government says it may have overpaid for the epinephrine autoinjectors.

Original Article: Mylan finalizes $465M settlement for EpiPen

NEXT ARTICLE

More From BioPortfolio on "Mylan finalizes $465M settlement for EpiPen"

Advertisement
Quick Search
Advertisement
Advertisement